All decks Close
All decks 5

  • Dr. Enrique Segura Ense Group - Supported Fundraising and Social Events

    Dr. Enrique Segura of ENSE Group is the CEO and President. He graduated from the Universidad Autonoma de Madrid. Visit at: https://lnk.bio/drenriqueseguraensegroup

    Jun 12, 2024 86 0

  • Dr. Enrique Segura Ense Group - Serves in Executive Leadership Roles

    Dr. Enrique Segura, CEO and President of ENSE Group, is a self-made entrepreneur and executive who received his education at Universidad Autonoma de Madrid. Visit at:-https://medium.com/@drenriqueseguraense

    Feb 23, 2024 158 0

  • Dr. Enrique Segura Ense Group - President of ENSE Group

    Dr. Enrique Segura is the founder of ENSE Group, a holding company overseeing Harbass, Alex Stewart International, Kibo Laboratories, and Securiport. He is the CEO and President of ENSE Group and holds executive positions at its subsidiaries. Visit at : https://www.flickr.com/photos/198329835@N04/

    Dec 04, 2023 213 0

  • Dr. Enrique Segura Ense Group Founder And Chairman of ENSE Group

    Dr. Enrique Segura is the founder and Chairman of ENSE Group, a holding company which oversees Alex Stuart International, Kibo Laboratories, Securiport, and Harbass. He sits on the Board of Directors for Catholic Charities of Washington, and he is the Vice Chairman of the Board of Trustees for the Catholic University of America. https://www.pinterest.com/drenriquesegura/

    Sep 08, 2023 529 0

  • Dr. Enrique Segura Ense Group - A Self-Made Entrepreneur

    Dr. Enrique Segura is a collector of Italian cars. A self-made entrepreneur, philanthropist, and successful executive, he received his Ph.D. in economics from Universidad Autonoma de Madrid. He regularly supports organizations such as Catholic Charities, the National Museum of Women in the Arts, the Catholic University of America, and the Smithsonian Institution. Dr. Enrique Segura serves on executive committees for all four companies held under ENSE Group. Visit at - https://www.behance.net/drenriquesegura

    Jul 18, 2023 378 0